Navigation Links
Medivation Reports Third Quarter 2010 Financial Results and Provides Corporate Update
Date:11/5/2010

SAN FRANCISCO, Nov. 5, 2010 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today provided a corporate update and reported its financial results for the third quarter ended September 30, 2010.

"In the third quarter, we began the expansion of our MDV3100 development program into earlier stage patients with the initiation of the Phase 3 PREVAIL trial, which is enrolling men with advanced prostate cancer who have not yet received chemotherapy.  Additionally, we believe that the positive interim analysis of the abiraterone Phase 3 study is a net positive for MDV3100, as it provides further clinical validation for the importance of the androgen receptor signaling pathway in advanced prostate cancer," said David Hung, MD, president and chief executive officer of Medivation.  "Together with our partner Pfizer, we continue to investigate dimebon's potential clinical benefit in the ongoing Phase 3 HORIZON trial in Huntington disease and the ongoing Phase 3 CONCERT trial in mild-to-moderate Alzheimer's disease patients who are taking donepezil.  We remain on track to complete enrollment in the CONCERT trial this year and look forward to announcing top-line results from the HORIZON trial in the first half of 2011."

Recent Accomplishments and Anticipated MilestonesMDV3100

  • Initiated the Phase 3 PREVAIL trial evaluating MDV3100 in men with advanced prostate cancer who have not yet received chemotherapy.  This randomized, double-blind, placebo-controlled, multi-national Phase 3 trial is expected to enroll approximately 1,700 patients globally.
  • Continued to enroll patients in the AFFIRM trial and expect to complete patient accrual on November 15, 2010. This randomized, double-blind, placebo-controlled Phase 3 trial is evaluating MDV3100 in men with advanced prostate cancer who have been previously treated with docetaxel-based che
    '/>"/>

  • SOURCE Medivation, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Medivation Announces Third Quarter 2010 Financial Results Teleconference and Webcast on November 5, 2010
    2. Medivation Announces Second Quarter 2010 Financial Results Teleconference and Webcast on August 9, 2010
    3. Medivation Announces Organizational Changes to Support Anticipated Growth and Future Commercialization
    4. Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update
    5. Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer
    6. Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer
    7. Medivation Announces Positive New Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients
    8. Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimers Disease
    9. Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients
    10. Medivation Presents Positive New Data on Dimebons Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimers Disease
    11. Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimers Disease
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/5/2015)... Big Market Research presents a detailed analysis of the ... ( France , Germany , ... Japan . Current scientific views on the Hepatitis ... test volume and sales forecasts by country for HAV NAT, HBV ... HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following ...
    (Date:5/5/2015)... , May 5, 2015 ... ( http://www.oramed.com ), a clinical-stage pharmaceutical company focused ... announced today that the company will present at ... Oppenheimer 16th Annual Israeli Conference , ,Date:   ... Nadav Kidron , Chief Executive Officer ,Time: ...
    (Date:5/5/2015)... -- E-QURE (Electric Quick Ulcer Remedy) Corp. ... of innovative medical devices in the field of advanced ... and the investment community, covering 2014 - 2015 business ... Bioelectrical Signal Therapy™ (BST) Device for advanced hard-to-heal wounds ... as its plans for commercialization and sale of the ...
    Breaking Medicine Technology:2015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 22015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 3Oramed to Present at Upcoming Conferences 2Oramed to Present at Upcoming Conferences 3E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 2E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 3E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 4E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 5
    ... Volcano Corporation (NASDAQ: VOLC ) today ... year, the Massachusetts Superior Court rejected claims by ... Medical, that Volcano Corporation and its wholly-owned subsidiary, ... for use in the development of Volcano,s Optical ...
    ... Tigris Pharmaceuticals, Inc., today announced enrollment of its first ... AFP-464 (aminoflavone prodrug) with or without Faslodex® (fulvestrant) in ... be used to pre-screen patients for a biomarker called ... predict sensitivity to AFP-464. It is ...
    Cached Medicine Technology:Statement From Volcano Corporation on Latest St. Jude Lawsuit 2Tigris Pharmaceuticals Initiates Randomized Phase 2 Study of AFP-464 in ER-Positive Breast Cancer Patients 2Tigris Pharmaceuticals Initiates Randomized Phase 2 Study of AFP-464 in ER-Positive Breast Cancer Patients 3
    (Date:5/5/2015)... 05, 2015 Okyanos, the leader in ... today. The study was conducted to determine the emotional ... osteoarthritis and sports-related injuries have had on those ... the most prevalent symptom reported at 73%, followed by ... standing and bending over. Over half of respondents, 56%, ...
    (Date:5/5/2015)... 05, 2015 On May, 5, 2015, My ... musician Irene Rose about alternatives for youngsters to do this ... you get the idea for starting a summer camp and ... an entertainment company called Once Upon a Party and I ... through songs and even scripture. We play games, sing, and ...
    (Date:5/5/2015)... On April 8th, 2015, at the famous Avalon ... Durkin Entertainment’s “RockNRolla” EcoLuxe Lounge, a daylong event organized ... placement in TV and film. , A gathering ... sound and socially conscious products and services, the EcoLuxe ... appearances at various awards ceremonies and festivals each year, ...
    (Date:5/5/2015)... May 05, 2015 For the growing list ... series of data loggers. This data logger series ... electronic components for optimum performance throughout exposure to high temperatures ... loggers are capable of storing up to 32,700 readings ... life of one year or longer. All data loggers in ...
    (Date:5/5/2015)... (PRWEB) May 05, 2015 Don’t have ... money for a fitness membership? Don’t know which workout ... these obstacles in order to help members achieve their ... Live Streaming Fitness, an educational, caused-based wellness company, today ... live streaming fitness classes led by certified trainers, nutritional ...
    Breaking Medicine News(10 mins):Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 2Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 3Health News:My Positive Perspective Hosts Episode Informing People of a True Princess Summer Camp With Irene Rose 2Health News:Choices Recovery Mishawaka Talks About Overcoming Adversity with Actor Matthew Ziff at the “RockNRolla Movie Awards” EcoLuxe Lounge 2Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 2Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 3Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 4Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 5Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 6Health News:Live Streaming Fitness Creates Industry Shift by Bringing Fitness, Nutrition and Cooking Classes to Smart Devices 2Health News:Live Streaming Fitness Creates Industry Shift by Bringing Fitness, Nutrition and Cooking Classes to Smart Devices 3
    ... Canada are raising a hue and cry over inadequate facilities in ... ill-equipped and many a times patients have to be treated in ... the B.C. Nurses' Union president Deb McPherson said that the status ... have no privacy and no direct access to a washroom, or ...
    ... reporting that the traditional method of assessing the heart ... danger //of missing one-third of women who are predisposed ... ,Roger Blumenthal, M.D., an associate professor and director ... Hopkins University School of Medicine and its Heart Institute ...
    ... The health services in Australia’s Townsville will be revolutionized after ... the James Cook University (JCU).// A rural medical school has ... JCU. The University’s new clinic will cost A$ 3 million, ... This will serve to give them experience with regard medicine ...
    ... to Food science and consumer acceptance in Norway the ... do experts to cheese.// ,The food compared was ... expert dairy assessors. The rating was based on reaction ... was difference of opinion in both factions. As a ...
    ... Researchers from the Pennsylvania State University are trying to determine ... the zebra fish. The team led by Mark Shriver studied ... change in their key gene plays a major role in ... of Science, may not only help explain why people of ...
    ... against cancer focusing at the molecular and genetic levels, ... coming under increasing scrutiny.// Now scientists at the University ... these supporting cells are indeed key players in the ... ,These findings were arrived at after studying a ...
    Cached Medicine News:Health News:Calcium Levels Could Indicate Future Heart Disease Risk 2Health News:Cancer Cells Trigger Supporting Cells to Turn Cancerous 2
    For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
    For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
    For the qualitative detection of luteinising Hormone (LH) in urine specimens...
    For the qualitative detection of luteinising Hormone (LH) in urine specimens...
    Medicine Products: